Emerging studies have identified a cardinal role for BVR-A in mitigating susceptibility to metabolic disorders through activation of a PPARα-dependent pathway via regulation of glycogen synthase kinase-3β (GSK3β) [62,63,64]. This evidence concerns the gene BLVRA and metabolic disease.